Quillivant XR 25 MG/5 ML susp 120ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1GEK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,473
Award facts
- Contract value 100% obligated
- $1,473.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,473.16 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 9, 2026, for the supply of Quillivant XR 25 mg/5 ml suspension in a 120 ml quantity. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by January 12, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems.
This delivery order was issued under AmerSourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products, specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. The contract demonstrates AmerSourceBergen's capability to fulfill federal medical supply requirements through open competition, with the company maintaining significant standing within DLA's Medical Supply Chain for delivering critical pharmaceutical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1GEK?
SPE2DR26F1GEK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F1GEK worth?
The government has obligated $1,473 on SPE2DR26F1GEK.
Is contract SPE2DR26F1GEK an order under another contract?
Yes. SPE2DR26F1GEK is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1GEK competed?
The extent of competition for SPE2DR26F1GEK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award